Progenity

BiotechnologySeries BSan Diego, USprogenity.com

Latest round

Series B

Last raised

Aug 2019

Total raised

$39M

Investors

1

About Progenity

Based in California, US, and founded in 2010, Progenity, Inc. is a biotechnology company that develops and commercializes molecular testing products. Harry Stylli is the current CEO of the company. The company went public in 2020. In 2020, Progenity, Inc.7 million shares at USD 15 per share on the NASDAQ, and became a publicly listed company under the ticker symbol PROG. The company develops genetic testing products including preparent (carrier test), innatal (prenatal screen), riscover (hereditary cancer testing), resura (prenatal test), and COVID-19 PCR Testing. The services that they offer are laboratory-developed prenatal genetic tests that can be used by patients, physicians, and clinicians to determine illnesses that can be passed to children.

Who invested in Progenity

1 investor across 2 rounds

See all investors in Progenity

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Aug 27, 2019

    Amount

    $25M

    Investors

    Locked

  2. Series A

    Jun 27, 2013

    Amount

    $14M

    Investors

    Locked

Questions about Progenity

Who invested in Progenity?

Progenity has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Progenity raised?

Progenity has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Progenity last raise money?

Progenity's most recent round on record is a Series B, in Aug 2019.

What does Progenity do?

Based in California, US, and founded in 2010, Progenity, Inc.

Where is Progenity headquartered?

Progenity is headquartered in San Diego, US.

Which VCs invest in companies like Progenity?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Progenity's stage. Their profiles are linked below.

Raising like Progenity? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.